ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Enhertu granted orphan drug designation in US for gastric cancer pharmaceutical-business-review
May 28, 2020?AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the treatment of patients with gastric cancer, including gastroesophageal junction cancer.
Pharma Sources Insight January 2025
